tiprankstipranks
EyePoint Pharmaceuticals Inc (EYPT)
NASDAQ:EYPT
US Market
EYPT
EyePoint Pharmaceuticals
RESEARCH TOOLSreports
Want to see EYPT full AI Analyst Report?

EyePoint Pharmaceuticals (EYPT) Income Statement

1,002 Followers

EyePoint Pharmaceuticals Income Statement

Last quarter (Q1 2026), EyePoint Pharmaceuticals's total revenue was $696.00K, a decrease of -97.15% from the same quarter last year. In Q1, EyePoint Pharmaceuticals's net income was $-84.83M. See EyePoint Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 31.37M$ 43.27M$ 46.02M$ 41.40M$ 36.94M
Gross Profit
$ 29.30M$ 39.56M$ 41.39M$ 33.08M$ 28.76M
Operating Expenses
$ 272.74M$ 185.41M$ 116.45M$ 132.72M$ 84.04M
Depreciation and Amortization
$ 0.00$ 1.54M$ 464.00K$ 2.45M$ 2.77M
EBITDA
$ -243.43M$ -129.23M$ -69.00M$ -96.62M$ -50.15M
Operating Income
$ -243.43M$ -145.85M$ -75.07M$ -99.64M$ -55.28M
Other Income/Expenses
$ 11.75M$ 15.07M$ 4.36M$ -2.62M$ -3.14M
Pretax Income
$ -231.68M$ -130.78M$ -70.71M$ -102.25M$ -58.42M
Net Income
$ -231.96M$ -130.87M$ -70.80M$ -102.25M$ -58.42M
Per Share Metrics
Basic EPS
$ -3.17$ -2.32$ -1.82$ -2.74$ -2.03
Diluted EPS
$ -3.17$ -2.32$ -1.82$ -2.74$ -2.03
Weighted Average Shares Outstanding
 73.25M 56.30M 38.90M 37.32M 28.76M
Weighted Average Shares Outstanding (Diluted)
 73.25M 56.30M 38.90M 37.32M 28.76M
Currency in USD

EyePoint Pharmaceuticals Earnings and Revenue History